AXA/2025/FY/Earnings presentation: Difference between revisions
Content deleted Content added
PlumBot: publish from draft |
PlumBot: publish from draft |
||
Line 67:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings and
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-
|-
| style="text-align:left" | Underlying earnings
|
|
|
|-
| style="text-align:left" |
|
|
|
|-
| style="text-align:left" |
|
|
|
|-
| style="text-align:left" |
|
|
|
|}
</div>
* '''Record profitability''': Further margin expansion in P&C and L&H; improvement in efficiency <sup>p. 6</sup>
* '''Scaling the business''': Continued investments in growth and technology <sup>p. 6</sup>
* Consistent earnings growth while enhancing reserve prudence <sup>p. 6</sup>
* Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX <sup>p. 6</sup>.
=== Diversified franchise, well positioned in an attractive industry ===
Line 105 ⟶ 104:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 gross written premium split (excluding AXA IM and holdings) <sup>p. 7</sup>
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
Line 125 ⟶ 124:
|}
</div>
* '''Secular trends fueling demand across businesses''': <sup>p. 7</sup>
** Protection gaps and emerging corporate risks (relevant for SME & Mid-market and Large & Specialty segments) <sup>p. 7</sup>
*** Demographics driving demand for private retirement and healthcare (relevant for Life and Health segments) <sup>p. 7</sup>
* '''Our right to win''': <sup>p. 7</sup>
** Leading brand & high customer NPS <sup>p. 7</sup>
** Strong and diversified distribution <sup>p. 7</sup>
** Technical expertise to price & underwrite risks <sup>p. 7</sup>
** Scale offering cost advantage <sup>p. 7</sup>
* Pie chart represents FY25 gross written premium split excluding AXA IM and holdings <sup>p. 7</sup>.
=== Laying the foundation for the next plan ===
Line 142 ⟶ 150:
=== Strong delivery across our businesses ===
<div style="overflow-x:auto">
{| class="wikitable"
! style="text-align:left" | Region
! class="col-m" style="text-align:right" | % of total GWP
! class="col-m" style="text-align:right" | Gross written premiums (EUR billion)
! class="col-m" style="text-align:right" | Underlying earnings (EUR billion)
|-
| style="text-align:left" | France
| class="col-m" style="text-align:right" | 27%
| class="col-m" style="text-align:right" | 31 (+6%)
| class="col-m" style="text-align:right" | 2.2 (+7%)
|-
| style="text-align:left" | Europe
| class="col-m" style="text-align:right" | 38%
| class="col-m" style="text-align:right" | 43 (+6%)
| class="col-m" style="text-align:right" | 3.5 (+9%)
|-
| style="text-align:left" | AXA XL
| class="col-m" style="text-align:right" | 17%
| class="col-m" style="text-align:right" | 19 (+4%)
| class="col-m" style="text-align:right" | 1.9 (+9%)
|-
| style="text-align:left" | Asia, Africa & EME-LATAM
| class="col-m" style="text-align:right" | 18%
| class="col-m" style="text-align:right" | 20 (+13%)
| class="col-m" style="text-align:right" | 1.5 (+6%)
|}
</div>
* Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX <sup>p. 10</sup>.
* ¹ FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers <sup>p. 10</sup>.
Line 177 ⟶ 202:
=== L&H | Good momentum, well positioned to capture growth opportunities ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ GWP breakdown by term <sup>p. 12</sup>
! style="text-align:left" | GWP EUR 57bn
! class="col-s" style="text-align:right" | —
|-
| style="text-align:left" | Short-term
| style="text-align:right" | 28%
|-
| style="text-align:left" | Long-term
| style="text-align:right" | 72%
|}
</div>
* '''Underlying earnings''' +7% to EUR 3.5bn (change FY25 vs. FY24 at constant FX) <sup>p. 12</sup>
* (diagram) '''2025 Strategic Focus''' <sup>p. 12</sup>
** '''Long-term business''': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>
Line 191 ⟶ 226:
** Increasing penetration of Protection riders in Savings offerings <sup>p. 12</sup>
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health <sup>p. 12</sup>
* '''FY25 Financial Performance''' <sup>p. 13</sup>
* Alban de Mailly Nesle <sup>p. 13</sup>
Line 217 ⟶ 251:
=== P&C | Delivering further margin expansion while enhancing reserve prudence ===
* (stacked bar) '''Combined ratio''' <sup>p. 15</sup>
** '''FY24 Total Combined Ratio''': 91.0% <sup>p. 15</sup>
*** Undiscounted CY loss ratio (ex Nat Cat): 67.4% <sup>p. 15</sup>
*** Expense ratio: 25.0% <sup>p. 15</sup>
*** Nat Cat: 3.8% <sup>p. 15</sup>
*** Prior year reserve development: -1.6% <sup>p. 15</sup>
*** Discount: -3.6% <sup>p. 15</sup>
** '''FY25 Total Combined Ratio''': 90.6% <sup>p. 15</sup>
*** Undiscounted CY loss ratio (ex Nat Cat): 67.0% <sup>p. 15</sup>
*** Expense ratio: 24.8% <sup>p. 15</sup>
*** Nat Cat: 3.4% <sup>p. 15</sup>
*** Prior year reserve development: -1.1% <sup>p. 15</sup>
*** Discount: -3.5% <sup>p. 15</sup>
* Better undiscounted current year loss ratio excluding Nat Cat from: <sup>p. 15</sup>
** Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting favorable pricing environment <sup>p. 15</sup>
** Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management <sup>p. 15</sup>
* Improvement in expense ratio reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology <sup>p. 15</sup>
* Nat Cat charges below normalized load <sup>p. 15</sup>
* Lower reliance on prior year reserve development <sup>p. 15</sup>
* Taking advantage of a good year to enhance reserve prudence <sup>p. 15</sup>
=== P&C | Earnings growth from higher underwriting and financial result ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | Change
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" | -
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | —
|-
| style="text-align:left" | Affiliates, FX & other
| style="text-align:right" | —
| style="text-align:right" | -150
| style="text-align:right" | —
|-
| style="text-align:left" | FY25
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 5,872
|}
</div>
* '''Underlying Earnings''' +9% (change at constant FX) <sup>p. 16</sup>
* '''Better underwriting result''' from strong volume growth and improved all-year combined ratio while enhancing reserve prudence <sup>p. 16</sup>
* '''Increase in investment income''' reflecting higher volumes and better reinvestment yields on fixed income assets <sup>p. 16</sup>
Line 298 ⟶ 360:
=== Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ===
* '''PVEP''' was impacted by higher interest rates on discounting despite strong growth in Life volumes (change at constant scope and FX) <sup>p. 18</sup>
* (bar) '''PVEP''' -2% <sup>p. 18</sup>
*** '''Protection & Health''': EUR 39.4bn <sup>p. 18</sup>
*** '''Unit-Linked''': EUR 8.5bn <sup>p. 18</sup>
*** '''Capital-light G/A''': EUR 2.0bn <sup>p. 18</sup>
*** '''Traditional G/A''': EUR 1.0bn <sup>p. 18</sup>
** FY25 Total: EUR 49.4bn <sup>p. 18</sup>
*** '''Protection & Health''': EUR 31.4bn (-4%) <sup>p. 18</sup>
*** '''Unit-Linked''': EUR 8.5bn (+18%) <sup>p. 18</sup>
*** '''Capital-light G/A''': EUR 7.8bn (-10%) <sup>p. 18</sup>
*** '''Traditional G/A''': EUR 1.7bn (-10%) <sup>p. 18</sup>
* '''NB CSM''' was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits <sup>p. 18</sup>
* (bar) '''NB CSM''' (pre-tax) +3% <sup>p. 18</sup>
** FY24: EUR 2.2bn <sup>p. 18</sup>
** FY25: EUR 2.2bn <sup>p. 18</sup>
* '''NBV''' was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France <sup>p. 18</sup>
* (bar) '''NBV''' (post-tax) stable <sup>p. 18</sup>
** FY24: EUR 2.3bn <sup>p. 18</sup>
** FY25: EUR 2.2bn <sup>p. 18</sup>
** '''NBV margin''': FY24 4.4%, FY25 4.5% <sup>p. 18</sup>
=== Life & Health | Growth in new business driving Normalized CSM growth ===
Line 378 ⟶ 402:
=== Life & Health | Strong momentum in both short-term and long-term business ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying Earnings waterfall <sup>p. 20</sup>
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | Change
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | FY24
| style="text-align:right" | 3,323
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-term technical margin
| style="text-align:right" | —
| style="text-align:right" | +60
| style="text-align:right" | 479
|-
| style="text-align:left" | Long-term result incl. CSM release
| style="text-align:right" | —
| style="text-align:right" | +156
| style="text-align:right" | 2,804
|-
| style="text-align:left" | Financial result
| style="text-align:right" | —
| style="text-align:right" | -11
| style="text-align:right" | 946
|-
| style="text-align:left" | Tax, FX and others
| style="text-align:right" | —
| style="text-align:right" | -27
| style="text-align:right" | -728
|-
| style="text-align:left" | FY25
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 3,501
|}
</div>
* '''Underlying Earnings''' +7% (change at constant FX) <sup>p. 20</sup>
* '''Strong short-term technical margin''' reflecting underwriting and claims initiatives that more than offset the impact of legislative change on the recoverability of value added tax in Mexico (EUR -0.1bn) <sup>p. 20</sup>
* '''Higher long-term results''' from increase in CSM release (+8%) reflecting growth in reserve base, including from favorable equity market performance, and better margins <sup>p. 20</sup>
Line 399 ⟶ 451:
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | '''Underlying earnings''' (constant FX)
| style="text-align:right" | 8.1
| style="text-align:right" | 8.4
| style="text-align:right" | +6%
|-
| style="text-align:left" | Property & Casualty
| style="text-align:right" | —
| style="text-align:right" | 5.9
| style="text-align:right" | +9%
|-
| style="text-align:left" | Life & Health
| style="text-align:right" | —
| style="text-align:right" | 3.5
| style="text-align:right" | +7%
|-
| style="text-align:left" | Asset Management
| style="text-align:right" | —
| style="text-align:right" | 0.2
| style="text-align:right" | -57%
|-
| style="text-align:left" | Holdings & other
| style="text-align:right" | —
| style="text-align:right" | -1.2
| style="text-align:right" | stable
|-
| style="text-align:left" | '''Net income''' (reported)
| style="text-align:right" | 7.9
| style="text-align:right" | 9.8
| style="text-align:right" | +26%
|-
| style="text-align:left" | Non-financial flows
| style="text-align:right" | -0.5
| style="text-align:right" | +2.1
| style="text-align:right" | —
|-
| style="text-align:left" | Capital gains from AXA IM disposal
| style="text-align:right" | —
| style="text-align:right" | +2.2
| style="text-align:right" | —
|-
| style="text-align:left" | Financial flows (incl. RCG)
| style="text-align:right" | +0.3
| style="text-align:right" | -0.7
| style="text-align:right" | —
|}
</div>
* (bar) '''Underlying earnings per share''': EUR 3.86 (FY25) vs EUR 3.59 (FY24), +8% <sup>p. 21</sup>
** +6% from earnings growth <sup>p. 21</sup>
Line 418 ⟶ 516:
* '''Financial flows''' lower, reflecting unfavorable forex impact <sup>p. 21</sup>
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | HY25
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | '''Shareholders' equity''' (Group share)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | SHE (excl. OCI)
| style="text-align:right" | 58.0
| style="text-align:right" | 52.7
| style="text-align:right" | 54.0
|-
| style="text-align:left" | Net OCI
| style="text-align:right" | -8.1
| style="text-align:right" | -7.2
| style="text-align:right" | -6.8
|-
| style="text-align:left" | SHE (excl. OCI & undated subordinated debt)
| style="text-align:right" | 53.2
| style="text-align:right" | 47.0
| style="text-align:right" | 49.4
|-
| style="text-align:left" | '''Debt gearing'''
| style="text-align:right" | 20.6%
| style="text-align:right" | 23.4%
| style="text-align:right" | 22.3%
|-
| style="text-align:left" | '''Underlying ROE'''
| style="text-align:right" | 15.2%
| style="text-align:right" | 17.5%
| style="text-align:right" | 16.0%
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Reconciliation of Shareholders' Equity <sup>p. 22</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24 to FY25
! class="col-s" style="text-align:right" | HY25 to FY25
|-
| style="text-align:left" | '''Opening Shareholders' equity'''
| style="text-align:right" | 49.9
| style="text-align:right" | 45.5
|-
| style="text-align:left" | Change in Net OCI
| style="text-align:right" | 1.3
| style="text-align:right" | 0.4
|-
| style="text-align:left" | Net income for the period
| style="text-align:right" | 9.8
| style="text-align:right" | 5.9
|-
| style="text-align:left" | Dividend
| style="text-align:right" | -4.6
| style="text-align:right" | —
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | -1.2
| style="text-align:right" | —
|-
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
| style="text-align:right" | -3.5
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Undated subordinated debt (including interest charges)
| style="text-align:right" | -0.3
| style="text-align:right" | -1.2
|-
| style="text-align:left" | Forex
| style="text-align:right" | -3.5
| style="text-align:right" | -0.1
|-
| style="text-align:left" | Other
| style="text-align:right" | -0.6
| style="text-align:right" | 0.3
|-
| style="text-align:left" | '''Closing Shareholders' equity'''
| style="text-align:right" | 47.2
| style="text-align:right" | 47.2
|}
</div>
== Higher organic cash remittance and robust cash position at Holding ==
Line 439 ⟶ 609:
=== Higher organic cash remittance and robust cash position at Holding ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | '''Net Cash Remittance'''
| style="text-align:right" | 7.7
| style="text-align:right" | 7.5
|-
| style="text-align:left" | Remittance ratio
| style="text-align:right" | 82%
| style="text-align:right" | 82%
|}
</div>
* FY24 breakdown: EUR 7.1bn (ordinary cash remittance) + EUR 0.6bn (proceeds related to in-force treaties²) <sup>p. 23</sup>
* '''FY24 Cash position''': EUR 4.0bn <sup>p. 23</sup>
* '''Net cash remittance from subsidiaries''': +EUR 7.5bn <sup>p. 23</sup>
Line 458 ⟶ 643:
=== Solvency II at 224% ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | '''Eligible Own Funds (EOF)'''
| style="text-align:right" | 55.9
| style="text-align:right" | 56.4
|-
| style="text-align:left" | '''Solvency Capital Requirement (SCR)'''
| style="text-align:right" | 25.9
| style="text-align:right" | 25.2
|-
| style="text-align:left" | '''Solvency II ratio'''
| style="text-align:right" | 216%
| style="text-align:right" | 224%
|}
</div>
* Changes: +EUR 0.2bn, +EUR 8.8bn, -EUR 0.4bn, -EUR 2.1bn, -EUR 6.0bn (Foreseeable dividends: EUR 4.8bn; Provision for annual Share buyback for 2026: EUR -1.25bn), -EUR 0.1bn <sup>p. 24</sup>
* Changes: EUR 0.0bn, +EUR 0.6bn, EUR 0.0bn, -EUR 1.2bn, EUR 0.0bn, -EUR 0.2bn <sup>p. 24</sup>
* '''Solvency II ratio''': 224% (FY25) vs 216% (FY24) <sup>p. 24</sup>
** '''Regulatory & model changes''': +0pts <sup>p. 24</sup>
** '''Normalized capital generation''': +28pts <sup>p. 24</sup>
Line 469 ⟶ 673:
** '''Dividend & annual share buyback''': -24pts <sup>p. 24</sup>
** '''Management actions, debt & other''': +2pts <sup>p. 24</sup>
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | Impact (pts)
|-
| style="text-align:left" | Interest rate +50bps
| style="text-align:right" | +2
|-
| style="text-align:left" | Interest rate -50bps
| style="text-align:right" | -1
|-
| style="text-align:left" | Corporate spreads +50bps
| style="text-align:right" | -1
|-
| style="text-align:left" | Euro Sovereign spreads +50bps
| style="text-align:right" | -7
|-
| style="text-align:left" | Credit migration
| style="text-align:right" | -4
|-
| style="text-align:left" | Listed Equity (excl. PE & Infra) +25%
| style="text-align:right" | -1
|-
| style="text-align:left" | Listed Equity (excl. PE & Infra) -25%
| style="text-align:right" | +2
|-
| style="text-align:left" | PE & Infra +25%
| style="text-align:right" | +14
|-
| style="text-align:left" | PE & Infra -25%
| style="text-align:right" | -19
|-
| style="text-align:left" | Inflation swap curve +50bps
| style="text-align:right" | -5
|}
</div>
* ¹Sensitivity to Euro sovereign spreads assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve (applied on sovereign and quasi-sovereign exposures) <sup>p. 24</sup>.
* ²Sensitivity to credit rating migration assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches) <sup>p. 24</sup>.
Line 485 ⟶ 717:
=== Solvency II -impact of the end of grandfathering period and Solvency II revision ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | Item
! class="col-m" style="text-align:right" | Impact
|-
| style="text-align:left" | '''Ratio as of 31/12/2025'''
| style="text-align:right" | 224%
|-
| style="text-align:left" | Impact of the end of grandfathering period on January 1, 2026
| style="text-align:right" | -10pts to 215%
|-
| style="text-align:left" | Impact of Solvency II revision to come into effect in 1Q27
| style="text-align:right" | +17pts
|}
</div>
* EUR 2.4bn grandfathered debt no longer eligible as capital from January 1, 2026 <sup>p. 25</sup>
* No change expected in organic capital generation <sup>p. 25</sup>
* Additional capital flexibility <sup>p. 25</sup>
* ¹Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date <sup>p. 25</sup>.
Line 586 ⟶ 832:
=== General Account invested assets ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | %
|-
| style="text-align:left" | '''Fixed income'''
| style="text-align:right" | 345
| style="text-align:right" | 77
|-
| style="text-align:left; padding-left:1.5em" | o/w Government bonds
| style="text-align:right" | 167
| style="text-align:right" | 37
|-
| style="text-align:left; padding-left:1.5em" | o/w Corporate bonds and loans
| style="text-align:right" | 121
| style="text-align:right" | 27
|-
| style="text-align:left; padding-left:1.5em" | o/w Other fixed income
| style="text-align:right" | 56
| style="text-align:right" | 13
|-
| style="text-align:left" | '''Real estate'''
| style="text-align:right" | 41
| style="text-align:right" | 9
|-
| style="text-align:left" | '''Infrastructure equity'''
| style="text-align:right" | 10
| style="text-align:right" | 2
|-
| style="text-align:left" | '''Listed equities'''
| style="text-align:right" | 10
| style="text-align:right" | 2
|-
| style="text-align:left" | '''Private equity and hedge funds'''
| style="text-align:right" | 23
| style="text-align:right" | 5
|-
| style="text-align:left" | '''Cash'''
| style="text-align:right" | 19
| style="text-align:right" | 4
|-
| style="text-align:left" | '''Policy loans'''
| style="text-align:right" | 2
| style="text-align:right" | 0
|-
| style="text-align:left" | '''Total Insurance Invested Assets'''
| style="text-align:right" | 450
| style="text-align:right" | 100
|}
</div>
* Duration gap: -0.4 year <sup>p. 33</sup>
* ¹ '''Other fixed income''' includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn) and Agency Pools (EUR 8bn) <sup>p. 33</sup>
* ² '''Listed equities''' includes hedges; Listed equities excluding hedges at EUR 14bn <sup>p. 33</sup>
Line 614 ⟶ 891:
=== Structured and Private Credit assets ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | EUR billion
|-
| style="text-align:left" | '''Residential Mortgages'''
| style="text-align:right" | 16
| style="text-align:right" | 4
|-
| style="text-align:left" | EUR 6bn Dutch mortgages, NHG guaranteed
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | '''CLO & ABS'''
| style="text-align:right" | 25
| style="text-align:right" | 6
|-
| style="text-align:left" | 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | '''Infrastructure debt'''
| style="text-align:right" | 8
| style="text-align:right" | 2
|-
| style="text-align:left" | Skewed towards resilient industries (Telecom, Utilities, Transport)
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | '''CRE debt'''
| style="text-align:right" | 8
| style="text-align:right" | 2
|-
| style="text-align:left" | Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | '''Mid-Market lending'''
| style="text-align:right" | 10
| style="text-align:right" | 2
|-
| style="text-align:left" | Strong diversification with EUR 8m average ticket
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | '''Other'''
| style="text-align:right" | 2
| style="text-align:right" | 0
|-
| style="text-align:left" | '''Total Structured and Private Credit Assets'''
| style="text-align:right" | 69
| style="text-align:right" | 15
|-
| style="text-align:left; padding-left:1.5em" | o/w 54% participating
| style="text-align:right" | —
| style="text-align:right" | —
|}
</div>
* G/A: General Account <sup>p. 34</sup>
=== Investment portfolio | Fixed Income reinvestment ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | Category
! class="col-s" style="text-align:right" | %
! class="col-s" style="text-align:right" | Average rating
|-
| style="text-align:left" | Government bonds & related
| style="text-align:right" | 32
| style="text-align:right" | AA
|-
| style="text-align:left" | Investment grade credit
| style="text-align:right" | 40
| style="text-align:right" | A
|-
| style="text-align:left" | ABS/CLO/IG fund financing
| style="text-align:right" | 21
| style="text-align:right" | —
|-
| style="text-align:left" | Below investment grade credit
| style="text-align:right" | 7
| style="text-align:right" | —
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 Fixed Income Reinvestment Yield <sup>p. 35</sup>
! style="text-align:left" | Category
! class="col-s" style="text-align:right" | Yield
|-
| style="text-align:left" | Public fixed income
| style="text-align:right" | 3.5%
|-
| style="text-align:left" | Private & Structured fixed income
| style="text-align:right" | 4.7%
|-
| style="text-align:left; font-weight:bold" | Total fixed income
| style="text-align:right; font-weight:bold" | 3.9%
|}
</div>
* Euro 57 billion fixed income invested at 3.9% <sup>p. 35</sup>
** Average duration of 9 years <sup>p. 35</sup>
** Includes EUR 19.7bn of Private & Structured Credit invested at 4.7% (CLOs, ABS, Infra & CRE debt, Fund financing and Private HY) <sup>p. 35</sup>
Line 650 ⟶ 1,010:
* ² '''Private & Structured fixed income''' refers to Private & Structured credit (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid) <sup>p. 35</sup>
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | Section
! class="col-s" style="text-align:right" | Page
|-
| style="text-align:left" | 1. Debt and Invested Assets
| style="text-align:right" | 31
|-
| style="text-align:left" | 2. Additional P&C disclosures
| style="text-align:right" | 36
|-
| style="text-align:left" | 3. Additional IFRS17 disclosures
| style="text-align:right" | 41
|-
| style="text-align:left" | 4. Sustainability
| style="text-align:right" | 44
|}
</div>
=== AXA XL Insurance | Large Commercial & Specialty business ===
Line 763 ⟶ 1,137:
|}
</div>
* Technical reserves include net undiscounted claims reserves and unearned premium reserves <sup>p. 38</sup>
=== P&C | 2026 Simplified Group Nat Cat Reinsurance Program 1 ===
Line 978 ⟶ 1,353:
* '''AEP''': Aggregate Exceedance Probability
* '''AI''': Artificial Intelligence
* '''AMF''': Autorité des
* '''APAC''': Asia-Pacific
* '''AY''': Accident Year
* '''BBA''':
* '''CDP''': Carbon Disclosure Project
* '''CLO''': Collateralized Loan Obligation
* '''CRE''': Commercial Real Estate
* '''CSA''': Corporate Sustainability Assessment
* '''CSM''': Contractual Service Margin
* '''CY''':
* '''DPS''': Dividend Per Share
* '''EME''': Emerging Markets
Line 994 ⟶ 1,370:
* '''ESMA''': European Securities and Markets Authority
* '''EU''': European Union
* '''EUR''': Euro
* '''FX''': Foreign Exchange
* '''GAAP''': Generally Accepted Accounting Principles
Line 1,012 ⟶ 1,389:
* '''NBV''': New Business Value
* '''NHG''': Nationale Hypotheek Garantie
* '''NPS''': Net Promoter Score
* '''OCI''': Other Comprehensive Income
* '''PAA''': Premium Allocation Approach
Line 1,017 ⟶ 1,395:
* '''PVEP''': Present Value of Expected Profits
* '''PYD''': Prior Years' Reserve Development
* '''RCG''':
* '''ROE''': Return On Equity
* '''SCR''': Solvency Capital Requirement
* '''SHE''': Shareholders' Equity
* '''SME''': Small and Medium-sized Enterprises
* '''TVOG''': Time Value of Options
* '''UEPS''': Underlying Earnings Per Share
* '''UK''': United Kingdom
| |||